Edwards Lifesciences has been granted a patent for methods and systems that utilize catheter-based techniques to repair heart tissue. The invention involves delivering a flexible implant to remodel heart structures by anchoring it with multiple tissue anchors, facilitating effective treatment of structural defects. GlobalData’s report on Edwards Lifesciences gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Edwards Lifesciences, Prosthetic cardiac valves was a key innovation area identified from patents. Edwards Lifesciences's grant share as of June 2024 was 46%. Grant share is based on the ratio of number of grants to total number of patents.
Heart tissue remodeling using catheter-based delivery methods
The patent US12035898B2 outlines a method for remodeling heart tissue in patients through a minimally invasive procedure. The process begins with the advancement of a guide catheter through the patient's vasculature to the heart, followed by the insertion of a delivery catheter. A heart remodeling implant, characterized by a flexible outer body with a tubular shape, is then delivered to the targeted heart tissue site. The implant is anchored in a curved configuration around the heart tissue using multiple tissue anchors. Each anchor is deployed sequentially into the tissue, and the outer body of the implant is subsequently contracted to draw the anchors closer together, effectively remodeling the heart tissue.
The method further details the use of an elastic member that interconnects the tissue anchors, allowing for controlled movement and anchoring. The elastic member can be a helically coiled wire, and the contraction of the outer body is achieved by reducing tension on this wire or by allowing the elastic outer body to contract. Each tissue anchor is initially housed in individual stowage capsules within the outer body, and the deployment process involves pushing the anchors out of these capsules into the heart tissue. The design includes features such as extension-rod passages for facilitating the delivery and deployment of the anchors, ensuring that the procedure is efficient and precise. Overall, this patent presents a novel approach to heart tissue remodeling that leverages advanced materials and techniques to improve patient outcomes.
To know more about GlobalData’s detailed insights on Edwards Lifesciences, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
